Nevanac

Nevanac Warnings

nepafenac

Manufacturer:

Novartis Healthcare

Distributor:

Zuellig
Full Prescribing Info
Warnings
There is a potential for cross-sensitivity to acetylsalicylic acid, phenylacetic acid derivatives, and other non-steroidal anti-inflammatory agents.
Therefore, caution should be used when treating individuals who have previously exhibited sensitivities to these drugs. With some non-steroidal anti-inflammatory drugs including Nepafenac (Nevanac) Sterile Ophthalmic Suspension, there exists the potential for increased bleeding time due to interference with thrombocyte aggregation. There have been reports that ophthalmic NSAIDs may cause increased bleeding of ocular tissues (including hyphemas) in conjunction with ocular surgery. Nepafenac (Nevanac) Sterile Ophthalmic Suspension should be used with caution in patients with known bleeding tendencies or who are receiving other medicinal products which may prolong bleeding time.
Nepafenac (Nevanac) Sterile Ophthalmic Suspension contains benzalkonium chloride which may cause eye irritation and is known to discolor soft contact lenses. Patients should be advised not to wear contact lenses during treatment with nepafenac (Nevanac) Sterile Ophthalmic Suspension. Benzalkonium chloride has been reported to cause punctate keratopathy and/or toxic ulcerative keratopathy. Close monitoring is required with frequent and/or prolonged use.
There is a potential for cross-sensitivity to acetylsalicylic acid, phenylacetic acid derivatives, and other non-steroidal anti-inflammatory agents.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in